These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 6493360)

  • 1. Treatment with clorgyline and pargyline differentially decreases clonidine-induced hypotension and bradycardia.
    Gutkind JS; Enero MA
    Naunyn Schmiedebergs Arch Pharmacol; 1984 Sep; 327(3):189-92. PubMed ID: 6493360
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selectivity of clorgyline and pargyline as inhibitors of monoamine oxidases A and B in vivo in man.
    Murphy DL; Lipper S; Slater S; Shiling D
    Psychopharmacology (Berl); 1979 Apr; 62(2):129-32. PubMed ID: 111275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronic treatment with the monoamine oxidase inhibitors clorgyline and pargyline down-regulates non-adrenoceptor [3H]-idazoxan binding sites in the rat brain.
    Olmos G; Gabilondo AM; Miralles A; Escriba PV; García-Sevilla JA
    Br J Pharmacol; 1993 Mar; 108(3):597-603. PubMed ID: 8385528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of the monoamine oxidase inhibitors clorgyline and pargyline on the hyperphagia of obese mice.
    Feldman JM
    Behav Brain Res; 1988 Jul; 29(1-2):147-58. PubMed ID: 2840925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of changes in alpha 2-adrenoceptor number and locomotor responses to clonidine following clorgyline discontinuation.
    Aulakh CS; Cohen RM; McLellan C; Murphy DL
    Br J Pharmacol; 1983 Sep; 80(1):10-2. PubMed ID: 6317126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of MAO-A activity enhances behavioural activity of rats assessed using water maze and open arena tasks.
    Barbelivien A; Nyman L; Haapalinna A; Sirviö J
    Pharmacol Toxicol; 2001 Jun; 88(6):304-12. PubMed ID: 11453370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for antagonistic activity of endothelin for clonidine induced hypotension and bradycardia.
    Gulati A
    Life Sci; 1992; 50(2):153-60. PubMed ID: 1309933
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The nature of the inhibition of rat liver monoamine oxidase types A and B by the acetylenic inhibitors clorgyline, l-deprenyl and pargyline.
    Fowler CJ; Mantle TJ; Tipton KF
    Biochem Pharmacol; 1982 Nov; 31(22):3555-61. PubMed ID: 6817759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction between cytosolic monoamine oxidase and spin-labeled amphetamine and its modification by clorgyline and pargyline.
    Copeland ES; Campbell IC; Murphy DL
    Biochim Biophys Acta; 1983 Feb; 743(1):186-94. PubMed ID: 6824699
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic clorgyline and pargyline increase apomorphine-induced stereotypy in the rat.
    Campbell IC; Durcan MJ; Cohen RM; Pickar D; Chugani D; Murphy DL
    Pharmacol Biochem Behav; 1985 Dec; 23(6):921-5. PubMed ID: 4080777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective pressor enhancement by monoamine oxidase inhibitors in conscious rats.
    Kerecsen L; Bunag RD
    J Pharmacol Exp Ther; 1989 Nov; 251(2):645-9. PubMed ID: 2509682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-induced changes in motor activity after selective MAO inhibition.
    Gianutsos G; Carlson GM; Godfrey JG
    Pharmacol Biochem Behav; 1983 Aug; 19(2):263-8. PubMed ID: 6634874
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Potentiation of para-hydroxyamphetamine-induced head-twitch response by inhibition of monoamine oxidase type A in the brain.
    Tadano T; Satoh S; Satoh N; Kisara K; Arai Y; Kim SK; Kinemuchi H
    J Pharmacol Exp Ther; 1989 Jul; 250(1):254-60. PubMed ID: 2501477
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of phenelzine and other monoamine oxidase inhibitor antidepressants on brain and liver I2 imidazoline-preferring receptors.
    Alemany R; Olmos G; García-Sevilla JA
    Br J Pharmacol; 1995 Feb; 114(4):837-45. PubMed ID: 7773544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of thymoxamine and its metabolites on clonidine-induced hypotension and bradycardia in rats.
    Roquebert J; Demichel P; Malek A
    Arch Int Pharmacodyn Ther; 1982 Jul; 258(1):116-27. PubMed ID: 6215903
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoamine oxidase in pancreatic islets, exocrine pancreas, and liver from rats. Characterization with clorgyline, deprenyl, pargyline, tranylcypromine, and amezinium.
    Lenzen S; Nahrstedt H; Panten U
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Nov; 324(3):190-5. PubMed ID: 6419132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Self-stimulation responses are altered following long-term but not short-term treatment with clorgyline.
    Aulakh CS; Cohen RM; Pradhan SN; Murphy DL
    Brain Res; 1983 Jul; 270(2):383-6. PubMed ID: 6883106
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of chronic regimens of clorgyline and pargyline on monoamine metabolism in the rat brain.
    Campbell IC; Robinson DS; Lovenberg W; Murphy DL
    J Neurochem; 1979 Jan; 32(1):49-55. PubMed ID: 32233
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of selective monoamine oxidase inhibitors on the in vivo release and metabolism of dopamine in the rat striatum.
    Butcher SP; Fairbrother IS; Kelly JS; Arbuthnott GW
    J Neurochem; 1990 Sep; 55(3):981-8. PubMed ID: 2117053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible melatonin involvement in the hypotensive effect of MAO inhibitors.
    Oxenkrug GF; McCauley RB; Fontana DJ; McIntyre IM; Commissaris RL
    J Neural Transm; 1986; 66(3-4):271-80. PubMed ID: 3097249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.